Another Contender in the Safety Syringe Arena

Last year we reported on the Ritract Safety Syringe, a special syringe designed to prevent accidental needlestick injuries. Maxxon Inc. announced today that their product, the Maxxon Safety Syringe, is nearing FDA-approval. The syringe uses a unique vacuum system to rapidly retract the needle once the injection is complete. The market for safety-engineered medical devices (SEMDs) is supposedly now valued at around $1.6 billion, so keep an eye out.
See a pretty nifty animation of the syringe in action here…